DMYTRUK MARK E. (Chief Financial Officer) reported 1 transaction at GINKGO BIOWORKS HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/17/2025ACC: 0001127602-25-009690
Officer· Chief Financial Officer
Since Sep 2021
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
9.50K acquired · 9.50K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+9.50K
Price / share
—
Trade value
—
% of position
27.4%
3/13/2025
34.65K→44.15K
Total
Net shares
+9.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 3/13/2025 | C · Conversion | +9.50K | — | — | 27.4% | 34.65K | 44.15K |
| Total | +9.50K | $0.00 | ||||||
Derivative Transactions1
Class B Common Stock
Direct
Converts to
Class A Common Stock
9.50K shares
Shares
−9.50K
Strike price
Held after
5.91K
Exercisable
—
3/13/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Class B Common Stock Direct | Class A Common Stock9.50K shares | 3/13/2025 | C · Conversion | −9.50K | — | 5.91K |